Pharma channel feed

Der­ma­vant taps AI for ‘white-glove’ web­site ser­vice for Vta­ma pso­ri­a­sis med

Last year
AI
Marketing

OTC nasal, ear care prod­uct man­u­fac­tur­er hand­ed a warn­ing let­ter

Last year
Manufacturing

In­cyte says JAK cream clears PhI­II eczema tri­al in chil­dren, but an­a­lysts are still watch­ing safe­ty

Last year
R&D

Up­dat­ed: FDA to im­port more of com­mon can­cer drug from Chi­na af­ter In­di­an site clo­sure

Last year
China
Manufacturing

Hu­mi­ra biosim­i­lar launch­es may serve as a test case for wider in­vest­ments, Biosim­i­lars Fo­rum leader cau­tions

Last year

Take­da pulls dengue vac­cine ap­pli­ca­tion af­ter FDA re­quests more da­ta

Last year
FDA+

Physi­cians see val­ue in con­sumer drug ads, but want more fi­nan­cial and ad­her­ence in­for­ma­tion, sur­vey finds

Last year
Marketing

Name that Hu­mi­ra biosim­i­lar: In­side the com­pli­cat­ed process to brand the newest ver­sions of Ab­b­Vie's drug

Last year
Marketing

No­var­tis faces one win, one loss in patent cas­es over block­buster heart fail­ure drug

Last year
Law

Avadel launch­es quick start to nar­colep­sy drug’s mar­ket­ing af­ter long road to ap­proval

Last year
Marketing

Bernie Sanders wants HHS to look in­to the price of Ei­sai's new­ly ap­proved Alzheimer's drug

Last year
Law

Melin­ta se­cures $142M BAR­DA deal to tar­get pe­di­atric and 'bio­threat' in­di­ca­tions for an­tibi­otics

Last year
Deals

Up­dat­ed: Eu­ro­pean reg­u­la­tors in­ves­ti­gat­ing 150 re­ports of self-in­jury, sui­cide risk in pa­tients tak­ing No­vo Nordisk meds for weight loss

Last year
Marketing

Pfiz­er adds shifts, in­vests re­sources to cope with surge in de­mand for syphilis treat­ment

Last year
Manufacturing

IRA will re­duce out-of-pock­et spend­ing among some Part D en­rollees by $7.4B in 2025, HHS re­port says

Last year

Lil­ly re­news Team USA Olympic and Par­a­lympic spon­sor­ship and signs on for Los An­ge­les 2028 Games

Last year
Marketing

Boehringer In­gel­heim un­veils lat­est fash­ion in­spired by rare skin dis­ease, cre­at­ed by de­sign stu­dents and men­tors

Last year
Marketing

CDC to re­duce fund­ing for states’ child vac­ci­na­tion pro­grams

Last year

No­vo Nordisk files sec­ond round of law­suits against com­pound­ing phar­ma­cies hawk­ing il­le­gal semaglu­tide

Last year

FDA grants full ap­proval to Leqem­bi, open­ing up cov­er­age of Alzheimer’s drug by Medicare

Last year
FDA+

Spring­Works stalled in pre-launch mode for brand com­mu­ni­ca­tions af­ter FDA de­ci­sion de­lay

Last year
Marketing

As­traZeneca launch­es aware­ness cam­paigns for physi­cians and pa­tients with dual asth­ma mes­sage

Last year
Marketing

GAO says FDA's al­lowance of phar­ma­cies to dis­pense abor­tion pill was not sub­ject to con­gres­sion­al re­view

Last year
FDA+

Gener­ic in­dus­try group sues Min­neso­ta, call­ing price caps 'un­con­sti­tu­tion­al'

Last year
Law
First page Previous page 112113114115116117118 Next page Last page
A service from the Financial Times